Uppugunduri S Chakradhara Rao

16PUBLICATIONS
61CO-AUTHORS
Predictive and prognostic markersInfant and child healthPharmacogenomicsMajor global burdens of diseaseGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 17, 2026
Molecular and Pharmacogenetic Marker Evaluation in Relation to the Toxicity and Clinical Response of Acute Lymphoblastic Leukemia Treatment in Indian Children (MPGx-INDALL): Protocol for a Prospective Observational Cohort Study.

Swetambri Sharma, Shuvadeep Ganguly, Kamali Murugadoss

|Mar 04, 2026
Refining busulfan exposure enhances pediatric ALL HSCT outcomes: insights from the International FORUM study.

Khalil Ben Hassine, Yvonne Sylvia Gloor, Isabelle Dupanloup

|Feb 19, 2026
Physiologically Based Pharmacokinetic Virtual Twin Approach for Fludarabine Dosing in Pediatric Hematopoietic Stem Cell Transplantation.

Mourad Mseddi, Christa Nath, Khalil Ben Hassine

|Nov 29, 2024
In vitro screening of UGT2B10 in silico prioritized putative ligands from drugs used in the pediatric hematopoietic stem cell transplantation setting.

Yahia Bennani, Khalil Ben Hassine, Muhammed Gencaslan

|Jul 02, 2024
Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2D6, ADRB1, ADRB2, ADRA2C, GRK4, and GRK5 Genotypes and Beta-Blocker Therapy.

Julio D Duarte, Cameron D Thomas, Craig R Lee

|Mar 16, 2024
A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care.

Santenna Chenchula, Shubham Atal, Chakradhara Rao S Uppugunduri

Pageof 3

Frequent Collaborators

4 joint publications

Marc Ansari

3 joint publications

Yvonne Sylvia Gloor

3 joint publications

Vid Mlakar

3 joint publications

Yves Chalandon